Our Innovation

We've focused on a new target, a proven drug and an innovative approach for drug delivery

Just the Right Target

An ion channel that controls the core features of disease in airway cells

TMEM16 is an ion channel expressed on airway smooth muscle and airway epithelial cells. When activated in disease, TMEM16 causes excessive calcium signaling that promotes inflammation and the primary sources of obstruction: namely smooth muscle tightening and too much mucus.

Just the Right Particle

Our engineered drug particles deliver drug to the site of disease- only where it's needed and not where it isn't needed.

Supercritical Precipitation (SCP) is a best-in-class technology for generating small particle dry powder formulation. When combined with a proven and easy-to-use delivery technology this will create airborne particles that flow via inhalation to the reach the target in the lungs and provide maximum efficacy.

Button Text

Aeon Respire Advantage

Our work to date has led to a patent protected therapy directed against a validated new target for respiratory disease. We are strategically positioned to advance quickly to clinical trials.

a great target

Only target to alleviate all major causes of poor breathing: smooth muscle tightening, excess mucus and upstream inflammatory signals

Learn More

a potent
lead in hand

Our lead program niclosamide is a potent TMEM16 inhibitor and an approved oral drug with a history of safety in humans

Learn More

SUPERIOR DELIVERY TECHNOLOGY

Inhalation delivery of particles generated by supercritical precipitation provides superior target coverage
where it's needed: in the lungs.

Learn More